SCHEMBL565799

SCHEMBL565799

CC(C)CN(Cc1cc(Cl)c2c(c1)CCCCO2)C(=O)[C@@H]1CCN(Cc2cccc3c2N(C)CC3)C1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.59
ACKR3 P25106 1/20 0.35
KDM4E B2RXH2 5/20 0.35
HTT P42858 3/20 0.33
ALDH1A1 P00352 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PDCD1 Q15116 2/20 0.32
CD274 Q9NZQ7 2/20 0.32
S1PR5 Q9H228 1/20 0.32
RAB9A P51151 1/20 0.32
DRD2 P14416 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10107458 1.00 PROKR2 (0.59) PROKR2ACKR3KDM4EHTTALDH1A1
SCHEMBL10120268 0.97 PROKR2 (0.60) PROKR2ACKR3KDM4EHTTALDH1A1
SCHEMBL10107493 0.97 PROKR2 (0.60) PROKR2ACKR3KDM4EHTTALDH1A1
SCHEMBL10119923 0.92 PROKR2 (0.71) PROKR2ACKR3KDM4EHTTALDH1A1
SCHEMBL10106678 0.92 PROKR2 (0.71) PROKR2ACKR3KDM4EHTTALDH1A1
SCHEMBL564955 0.88 PROKR2 (0.71) PROKR2ACKR3KDM4EHTTALDH1A1
SCHEMBL10107284 0.88 PROKR2 (0.71) PROKR2ACKR3KDM4EHTTALDH1A1
SCHEMBL10107446 0.88 PROKR2 (0.61) PROKR2ACKR3KDM4EHTTALDH1A1
SCHEMBL565480 0.88 PROKR2 (0.61) PROKR2ACKR3KDM4EHTTALDH1A1
SCHEMBL10107442 0.87 PROKR2 (0.60) PROKR2ACKR3KDM4EHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885ACKR3 411/4885KDM4E 4874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.